Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services
Celerion Expands Early Phase Clinical Pharmacology Units
read more
Pharmaceutical Cleanroom Industry Articles
CARsgen Therapeutics launches 37,000-ft cleanroom facility for clinical and early-stage commercial manufacturing
CARsgen Therapeutics 37,000-ft facility for clinical and early-stage commercial manufacturing was designed and built in just 12 months.
On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility
The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency
NuTec Employs Epson Cleanroom SCARA Robots to Automate Medical Syringe Manufacturing, Including a COVID-19 Medical Application
Cleanroom SCARA Robots to Automate Medical Syringe Manufacturing, Including a COVID-19 Medical Application
NuTec’s Syringe Coating Machine Includes Four Epson G6 Cleanroom SCARA Robots to Precisely, Efficiently, and Cost-Effectively Automate Syringe Manufacturing
Nanotech Powered Mass Testing Now the Key to Unlocking COVID-19 Lockdowns
The World Nano Foundation and pandemic experts say regular use of inexpensive lateral flow rapid antigen mass testing kits is the way to beat COVID-19, its variants and future viruses.
Heska Corporation to Acquire Lacuna Diagnostics, a Pioneer and Market Leader in Point-of-Care Digital Cytology
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the “Agreement”) to acquire 100% of Lacuna Diagnostics, Inc. (“Lacuna”), a pioneer and market leader in point-of-care diagnostics digital cytology technology and telemedicine services.
Prime Minister announces £20m to grow medicines manufacturing in the UK
The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.
Purolite Announces Expansion to Address the High-demand for Pharmaceutical Products
Purolite Corporation is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its pharmaceutical and life science products. The new facility will include two new cleanrooms to manufacture active pharmaceutical ingredients (APIs) and excipients and an agarose manufacturing facility equipped with proprietary jetting technology for the capture and purification of (mAbs) monoclonal antibodies sold under the Praesto® brand.
SteriPack Group announces global rollout of sterile swabs to help combat Covid-19
SteriPack Group rapidly deploys equipment, expertise and facilities to meet critical need for sterile swabs, diagnostic products and personal protective equipment across their global manufacturing network.
Thermo Fisher Scientific Announces Expands Sterile Filling Capacity for Therapies and Vaccines
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufacture of therapies and vaccines.
ALK Life Science Solutions and UPPI Announce Partnership to Provide High-Quality Vials for Improved Patient Care
ALK Life Science Solutions, a business unit of ALK-Abelló, Inc. (ALK), serving the North American pharmaceutical packaging-based market for glass vials, and UPPI, LLC, the largest association of independent and university-based nuclear pharmacies serving the diagnostic imaging community in the U.S., announced today that they have entered into a three-year partnership to provide high-quality glass vials to UPPI members providing unit dose radiopharmaceuticals and positron emission tomography (PET) manufacturing of radiopharmaceuticals for use in nuclear imaging tests and treatments.
Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos’ Cord Blood T-Regulatory Cells
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by Cellenkos®), published in peer reviewed journal of Annals of Internal Medicine.